Lundbeck’s Vyepti Sales Disappoint But Lower Costs Boost Profitability

Danish Firm Hoping For More From Migraine Drug

Migraine, conceptual computer illustration.
Migraine Drug Vyepti Had Been Touted As Transformational For The Firm • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Business